Helix Biopharma Corp. HBPCF
—
1.71
0.00
0.00%
as of 24 Sep
- Market cap
- —
- P/E
- 0.0×
Follow HBPCF
Growth Flags
show if company had growth for consecutive years
| Apr '26 | Jan '26 | Oct '25 | Jul '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.43 | 0.02 | 0.18 | 0.06 | |
Current Ratio |
0.45 | 0.04 | 0.23 | 0.13 | |
Net Debt/EBITDA |
3.60 | (0.48) | 0.16 | (0.28) | |
Debt/Assets |
1.68% | 1.94% | 1.85% | 1.78% | |
Debt/Equity |
0.02 | 0.02 | 0.02 | 0.02 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.34 | 0.66 | 1.21 | 0.72 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.22 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.86 | 0.99 | 0.96 | 0.98 | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | 0.00 | (0.01) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.01) | 0.00 | (0.01) | (0.01) | |
Cash per Share |
0.03 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.14 | 0.15 | 0.15 | 0.20 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.14 | 0.15 | 0.15 | 0.20 | |
Free Cash Flow |
(0.65) | (0.33) | (0.88) | (0.51) | |
Working Capital |
(2.70) | (2.18) | (1.68) | (2.01) | |
Capital Expenditures |
— | — | — | 0.00 | |
Net Current Asset Value |
(2.70) | (2.18) | (1.68) | (2.01) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.02 | 0.02 | 0.03 | 0.06 | |
Average Payables |
1.81 | 1.81 | 1.60 | 1.61 | |
Average Assets |
8.15 | 7.47 | 7.02 | 7.29 | |
Average Common Equity |
4.87 | 5.53 | 5.29 | 5.55 |
Columns are period end dates